CMS

Intellectual Property, Life Sciences & Healthcare ,TMC (technology, media & telecommunications), ESG,

Gabriela Staber is an attorney-at-law specialising in intellectual property and unfair competition law with a sector focus on life sciences & healthcare and TMC (technology, media & telecommunications).  She advises on issues related to the marketing and distribution of pharmaceuticals and medical devices as well as the protection of intellectual property. Her expertise includes advertising and product labelling, compliance, restructuring of distribution systems, reimbursement / market access, clinical trials, licensing, counterfeits and parallel imports and dispute resolution.

Her clients include pharmaceutical, medical device and biotechnology companies, healthcare start-ups and online pharmacies

English; German,

2011 – Bar admission in New York and Massachusetts 2010 – LL.M. in Intellectual Property and Information Technology Law & U.S. Law, Suffolk Law School (Boston) 2007 – Bar admission in Austria 2004 – Doctor iuris in Commercial Law (Antitrust Law), University of Vienna 2001 – LL.M. in European Law, King’s College London 1999 – Master of Laws, University of Vienna

Gabriela Staber regularly publishes in specialist journals. She has co-authored of commentaries on the European Union Trademark Regulation and the Community Design Regulation, as well as contributing to the publication Distribution & Marketing of Drugs. She regularly lectures and holds trainings in the abovementioned fields.